1.Nakic Rados S, Kosec V, Gall V: The psychological effects of prenatal diagnostic procedures: maternal anxiety before and after invasive and noninvasive procedures. Prenat Diagn 2013, 33(12):1194–1200.
2.Richmond Z, Fleischer R, Chopra M, Pinner J, D’Souza M, Fridgant Y, Hyett J: The impact of non-invasive prenatal testing on anxiety in women considered at high or low risk for aneuploidy after combined first trimester screening. Prenat Diagn 2017, 37(10):975–982.
3.van Schendel RV, Page-Christiaens GC, Beulen L, Bilardo CM, de Boer MA, Coumans AB, Faas BH, van Langen IM, Lichtenbelt KD, van Maarle MC et al: Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women’s perspectives. Prenat Diagn 2016, 36(12):1091–1098.
4.Lo TK, Chan KY, Kan AS, So PL, Kong CW, Mak SL, Lee CN: Decision outcomes in women offered noninvasive prenatal test (NIPT) for positive Down screening results. J Matern Fetal Neonatal Med 2019, 32(2):348–350.
5.Garcia E, Timmermans DR, van Leeuwen E: Rethinking autonomy in the context of prenatal screening decision-making. Prenat Diagn 2008, 28(2):115–120.
6.Koletzko SH, La Marca-Ghaemmaghami P, Brandstatter V: Mixed Expectations: Effects of Goal Ambivalence during Pregnancy on Maternal Well-Being, Stress, and Coping. Appl Psychol Health Well Being 2015, 7(3):249–274.
7.Conner M, Povey R, Sparks P, James R, Shepherd R: Moderating role of attitudinal ambivalence within the theory of planned behaviour. Br J Soc Psychol 2003, 42(Pt 1):75–94.
8.Jallinoja P, Hakonen A, Aro AR, Niemela P, Hietala M, Lonnqvist J, Peltonen L, Aula P: Attitudes towards genetic testing: analysis of contradictions. Soc Sci Med 1998, 46(10):1367–1374.
9.Dormandy E, Michie S, Hooper R, Marteau TM: Informed choice in antenatal Down syndrome screening: a cluster-randomised trial of combined versus separate visit testing. Patient Educ Couns 2006, 61(1):56–64.
10.Lewis DA, O’Shea H, Church TK, Brambilla G, Traini D, Young PM: Exploring the impact of sample flowrate on in vitro measurements of metered dose inhaler performance. Int J Pharm 2016, 514(2):420–427.
11.Yotsumoto J, Sekizawa A, Suzumori N, Yamada T, Samura O, Nishiyama M, Miura K, Sawai H, Murotsuki J, Kitagawa M et al: A survey on awareness of genetic counseling for non-invasive prenatal testing: the first year experience in Japan. J Hum Genet 2016, 61(12):995–1001.
12.Reid B, Sinclair M, Barr O, Dobbs F, Crealey G: A meta-synthesis of pregnant women’s decision-making processes with regard to antenatal screening for Down syndrome. Soc Sci Med 2009, 69(11):1561–1573.
13.Hurford E, Hawkins A, Hudgins L, Taylor J: The decision to continue a pregnancy affected by Down syndrome: timing of decision and satisfaction with receiving a prenatal diagnosis. J Genet Couns 2013, 22(5):587–593.
14.Reed AR, Berrier KL: A Qualitative Study of Factors Influencing Decision-Making after Prenatal Diagnosis of down Syndrome. J Genet Couns 2016.
15.van Schendel RV, Kater-Kuipers A, van Vliet-Lachotzki EH, Dondorp WJ, Cornel MC, Henneman L: What Do Parents of Children with Down Syndrome Think about Non-Invasive Prenatal Testing (NIPT)? J Genet Couns 2017, 26(3):522–531.
16.Williams C, Alderson P, Farsides B: Is nondirectiveness possible within the context of antenatal screening and testing? Soc Sci Med 2002, 54(3):339–347.
17.Perry CL, Henry MJ: Exploring adoption with clients: the need for adoption education within the genetic counseling profession. J Genet Couns 2010, 19(4):305–314.
18.Allison SJ, Stafford J, Anumba DO: The effect of stress and anxiety associated with maternal prenatal diagnosis on feto-maternal attachment. BMC Womens Health 2011, 11:33.
19.McMahon CA, Ungerer JA, Beaurepaire J, Tennant C, Saunders D: Anxiety during pregnancy and fetal attachment after in-vitro fertilization conception. Hum Reprod 1997, 12(1):176–182.
20.McMahon CA, Boivin J, Gibson FL, Hammarberg K, Wynter K, Saunders D, Fisher J: Pregnancy-specific anxiety, ART conception and infant temperament at 4 months post-partum. Hum Reprod 2013, 28(4):997–1005.
21.Fisher J, Wynter K, Hammarberg K, McBain J, Gibson F, Boivin J, McMahon C: Age, mode of conception, health service use and pregnancy health: a prospective cohort study of Australian women. BMC Pregnancy Childbirth 2013, 13:88.
22.Hjelmstedt A, Widstrom AM, Collins A: Psychological correlates of prenatal attachment in women who conceived after in vitro fertilization and women who conceived naturally. Birth 2006, 33(4):303–310.
23.Tendais I, Figueiredo B: Parents’ anxiety and depression symptoms after successful infertility treatment and spontaneous conception: does singleton/twin pregnancy matter? Hum Reprod 2016, 31(10):2303–2312.
24.Kleinveld JH, Timmermans DR, de Smit DJ, Ader HJ, van der Wal G, ten Kate LP: Does prenatal screening influence anxiety levels of pregnant women? A longitudinal randomised controlled trial. Prenat Diagn 2006, 26(4):354–361.
25.van den Berg M, Timmermans DR, ten Kate LP, van Vugt JM, van der Wal G: Informed decision making in the context of prenatal screening. Patient Educ Couns 2006, 63(1–2):110–117.
26.Richards EG, Sangi-Haghpeykar H, McGuire AL, Van den Veyver IB, Fruhman G: Pregnant patients’ risk perception of prenatal test results with uncertain fetal clinical significance: ultrasound versus advanced genetic testing. Prenat Diagn 2015, 35(12):1213–1217.
27.Sapp JC, Hull SC, Duffer S, Zornetzer S, Sutton E, Marteau TM, Biesecker BB: Ambivalence toward undergoing invasive prenatal testing: an exploration of its origins. Prenat Diagn 2010, 30(1):77–82.